[go: up one dir, main page]

DD128682A5 - Verfahren zur herstellung neuer halogenpregnadiene - Google Patents

Verfahren zur herstellung neuer halogenpregnadiene

Info

Publication number
DD128682A5
DD128682A5 DD7600196260A DD19626076A DD128682A5 DD 128682 A5 DD128682 A5 DD 128682A5 DD 7600196260 A DD7600196260 A DD 7600196260A DD 19626076 A DD19626076 A DD 19626076A DD 128682 A5 DD128682 A5 DD 128682A5
Authority
DD
German Democratic Republic
Prior art keywords
names
spread
producing new
new halogen
halogen
Prior art date
Application number
DD7600196260A
Other languages
English (en)
Inventor
Georg Anner
Charles Meystre
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DD128682A5 publication Critical patent/DD128682A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
DD7600196260A 1975-12-12 1976-12-10 Verfahren zur herstellung neuer halogenpregnadiene DD128682A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1615075A CH626632A5 (en) 1975-12-12 1975-12-12 Process for the preparation of halopregnadienes

Publications (1)

Publication Number Publication Date
DD128682A5 true DD128682A5 (de) 1977-12-07

Family

ID=4414834

Family Applications (1)

Application Number Title Priority Date Filing Date
DD7600196260A DD128682A5 (de) 1975-12-12 1976-12-10 Verfahren zur herstellung neuer halogenpregnadiene

Country Status (19)

Country Link
JP (1) JPS5273852A (de)
AT (1) AT353432B (de)
AU (1) AU510864B2 (de)
BE (1) BE849267A (de)
CA (1) CA1078824A (de)
CH (2) CH626632A5 (de)
DD (1) DD128682A5 (de)
DE (1) DE2655802A1 (de)
DK (1) DK142326B (de)
ES (2) ES454119A1 (de)
FR (1) FR2358152A1 (de)
GB (1) GB1563595A (de)
HU (1) HU176936B (de)
IE (1) IE44512B1 (de)
IL (1) IL51085A (de)
NL (1) NL7613711A (de)
NZ (1) NZ182865A (de)
SE (1) SE7613919L (de)
ZA (1) ZA767381B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid

Also Published As

Publication number Publication date
AU2047176A (en) 1978-06-15
ZA767381B (en) 1977-11-30
HU176936B (hu) 1981-06-28
FR2358152A1 (fr) 1978-02-10
FR2358152B1 (de) 1982-10-22
IE44512B1 (en) 1981-12-30
JPS5273852A (en) 1977-06-21
DK142326C (de) 1981-03-09
IE44512L (en) 1977-06-12
DK557576A (de) 1977-06-13
IL51085A0 (en) 1977-02-28
DE2655802A1 (de) 1977-06-16
SE7613919L (sv) 1977-06-13
BE849267A (fr) 1977-06-10
ATA914176A (de) 1979-04-15
CA1078824A (en) 1980-06-03
IL51085A (en) 1980-09-16
CH626632A5 (en) 1981-11-30
NZ182865A (en) 1979-06-08
ES465551A1 (es) 1978-09-16
DK142326B (da) 1980-10-13
NL7613711A (nl) 1977-06-14
CH626094A5 (en) 1981-10-30
AT353432B (de) 1979-11-12
GB1563595A (en) 1980-03-26
ES454119A1 (es) 1978-03-01
AU510864B2 (en) 1980-07-17

Similar Documents

Publication Publication Date Title
AT366361B (de) Verfahren zur herstellung neuer 2-aminotetraline
AT362363B (de) Verfahren zur herstellung neuer azetidinole
AT371139B (de) Verfahren zur herstellung neuer bitumenzusammen- setzungen
AT351510B (de) Verfahren zur herstellung neuer substituierter fluoracylresorcine
AT355041B (de) Verfahren zur herstellung neuer n,n'-thio-bis- oximcarbamate
AT343808B (de) Verfahren zur herstellung neuer rifamycin-verbindungen
DD130431A5 (de) Verfahren zur herstellung neuer kondensierter pyrimidin-derivate
AT346843B (de) Verfahren zur herstellung neuer heteroaryl- verbindungen
AT352918B (de) Verfahren zur herstellung neuer histidin- derivate
AT344897B (de) Verfahren zur herstellung neuer rifamycin-verbindungen
DD132438A5 (de) Verfahren zur herstellung neuer kortikoide
AT351046B (de) Verfahren zur herstellung neuer diharnstoffe
DD128682A5 (de) Verfahren zur herstellung neuer halogenpregnadiene
AT359059B (de) Verfahren zur herstellung neuer 1-methyl-2- (phenyl-oxymethyl)-5-nitroimidazolderivate
AT360971B (de) Verfahren zur herstellung neuer alkinole
DD129653A5 (de) Verfahren zur herstellung neuer halogenpregnadiene
AT357516B (de) Verfahren zur herstellung neuer 2,3-dihydro- benzofuranon-2-derivate
AT341531B (de) Verfahren zur herstellung neuer octahydropyridoindolobenzazepine
DD131169A5 (de) Verfahren zur herstellung neuer azatetracyclen
ATA759579A (de) Verfahren zur herstellung neuer ergolinderivate
ATA759479A (de) Verfahren zur herstellung neuer ergolinderivate
AT352733B (de) Verfahren zur herstellung neuer thieno-4,1- oxazepine
AT360538B (de) Verfahren zur herstellung neuer 1,4-dihydro- pyridinderivate
AT355027B (de) Verfahren zur herstellung neuer benzodiazepin- derivate
ATA700078A (de) Verfahren zur herstellung neuer vincanol- und epivincanolderivate